Atombio selected for the BioTools Innovator accelerator

Joining BioTools Innovator

Atombio is excited to announce its selection for the BioTools Innovator accelerator program, a premier platform supporting emerging companies developing transformative tools and technologies for the life sciences industry. Participation in the program provides Atombio with access to industry-leading mentors, strategic partners, and a global network of biotechnology innovators focused on accelerating the future of therapeutic development.

Joining BioTools Innovator advances Atombio' mission to modernize mRNA engineering through AI-driven sequence optimization across multiple functional properties. The program strengthens the company's ability to scale its platform, validate new approaches for therapeutic mRNA design, and collaborate with leaders across synthetic biology, drug development, and biomanufacturing. By combining advanced machine learning with next-generation nucleic acid engineering, Atombio aims to enable faster development of safer, more effective RNA therapeutics.